Proffered Paper - Public Policy
Invited Discussant 1581O_PR and LBA66_PR
Date
21 Sep 2020Session
Proffered Paper - Public PolicyPresenters
Rosa GiulianiAuthors
R. GiulianiAuthor affiliations
- Medical Oncology Department, The Clatterbridge Cancer Centre, L9 7AL - Liverpool/GB
Resources
Resources from the same session
1581O_PR - Estimation of European cancer burden for the year 2020
Presenter: Tadeusz Dyba
Session: Proffered Paper - Public Policy
Resources:
Abstract
Slides
Webcast
LBA66_PR - Disparities in access to oncology clinical trials in Europe in the period 2009-2019
Presenter: Ana Carneiro
Session: Proffered Paper - Public Policy
Resources:
Abstract
Slides
Webcast
1582O - Developing a real-world outcomes forecast model using matched oncology clinical trials and real world evidence to inform policy-making and reimbursement approaches
Presenter: Jennifer Hinkel
Session: Proffered Paper - Public Policy
Resources:
Abstract
Slides
Webcast
1583O - Clinical benefit of cancer drugs approved in Switzerland during the last decade
Presenter: Roman Adam
Session: Proffered Paper - Public Policy
Resources:
Abstract
Slides
Webcast
1584O - Health technology assessment (HTA) in England, France and Germany: What do we know about variations in cancer-related HTA outcomes?
Presenter: Ramon Schaefer
Session: Proffered Paper - Public Policy
Resources:
Abstract
Slides
Webcast
Q&A and live discussion
Presenter: Rosa Giuliani
Session: Proffered Paper - Public Policy
Resources:
Webcast
Invited Discussant 1582O, 1583O and 1584O
Presenter: Christophe Le Tourneau
Session: Proffered Paper - Public Policy
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Rosa Giuliani
Session: Proffered Paper - Public Policy
Resources:
Webcast